Dr Harshadeep Kamble, commissioner, FDA, said it has been noticed that use of electronic cigarettes, which contain nicotine, is on the rise, especially among the youth and college-going students.
Considering the ill-effects of smoking of e-cigarettes, show-cause notices were issued, he said.
Sale of lozenges/gums containing less than 2 mg of nicotine is permissible, while the products which contain more nicotine are sold only on the prescription of medical practitioners.
As per the Drugs and Cosmetics Act, every new drug should be sold with the prior approval of Drugs Controller General of India, but such an approval has not been given for these e-cigarettes, he said.
Contravention of relevant provisions of Drugs and Cosmetics Act can attract imprisonment of three to five years.
Kamble said that in Mumbai alone 23 importers/ sellers were issued notices.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
